Our laboratory produces a range of penile injections available on prescription which include:
(1) Alprostadil monotherapy – concentrations of 5 to 40mcg/ml are available.
(2) BIMIX – a combination of alprostadil and phentolamine of varying strengths are available.Usual prescribed strengths: Phentolamine 0.5 -2.0mg + alprostadil 10-20mcg.
(3) TRIMIX – a combination of alprostadil, phentolamine and papaverine are available of varying strengths. Combination therapy was first introduced in 1991 by Bennett and his colleagues who demonstrated a success rate of TriMix of 92% in 116 patients.Usual prescribed strength: Papaverine 12.5-30mg + Phentolamine 0.5 -2.0mg + alprostadil 10-80mcg
(4) QUADMIX – a combination of alprostadil, phentolamine, papaverine and atropine are available in varying strengths. QuadMix includes the addition of atropine which may work synergistically to cause smooth muscle relaxation in the penis. In a study conducted by Israilov and colleagues, 13 patients that failed tri-mix had a positive response to quad-mix. Usual prescribed strength: Papaverine 12.5-30mg + Phentolamine 0.5-2.0mg + alprostadil 10-80mcg + Atropine 0.02-0.08mg
(5) Pap.P&A – phentolamine, papaverine and atropine. Usual prescribed strength: Papaverine 12.5-40mg + Phentolamine 0.5-2.0mg + Atropine 0.02-0.08mg
These injections produce less pain, are more affordable and more potent when compared to standard therapy and are recommended by most ED specialists. There are over a dozen common injection combinations made by our laboratory in order to cover the wide range of needs observed within the male population.
Our laboratory has been producing and supplying these injections for over 10 years and are one of the most experienced in this area. We courier these injections Australia wide via overnight courier. Contact us for more information.
References:
Bennett AH, Carpenter AJ, Barada JH: An improved vasoactive drug combination for a pharmacological erection program. J Urol 1991; 146:1564-1565.
Israilov S, Niv E, Livne PM, Shmueli J, Engelstein D, Segenreich E, Baniel J. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate. Int J Impot Res. 2002 Feb;14(1):38-43.
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
